Evolocumab (Repatha) for the Treatment of Hyperlipidemia

被引：0
|
作者：
Erlich, Deborah R. [1 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
AMERICAN FAMILY PHYSICIAN | 2016年 / 94卷 / 10期
关键词：
TRIAL;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：843 / 846
页数：4
相关论文
共 50 条
  • [1] Evolocumab (Repatha (R))
    Turecek, Claudia
    JOURNAL FUR KARDIOLOGIE, 2016, 23 (1-2): : 58 - 58
  • [2] Reduction of Cardiovascular Risk with Evolocumab (Repatha)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1519): : 63 - 64
  • [3] Repatha Pushtronex - A New Evolocumab Injection Device
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1503): : 120 - 120
  • [4] Evolocumab in Hyperlipidemia
    Meyer, Robert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (09): : 876 - 876
  • [5] Evolocumab as treatment in lorlatinib-related hyperlipidemia
    Alonso, Laura Perez
    Calero, Raquel Cervera
    de Sevilla, Maria Angeles Campos Fernandez
    Palanco, Miguel Angel Moreno
    Cerezo, Jorge Francisco Gomez
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2023, 35 (02): : 88 - 90
  • [6] Profile of evolocumab and its potential in the treatment of hyperlipidemia
    Cicero, Arrigo F. G.
    Colletti, Alessandro
    Borghi, Claudio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3073 - 3082
  • [7] Evolocumab: A Review in Hyperlipidemia
    Keating, Gillian M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (01) : 67 - 78
  • [8] Evolocumab: A Review in Hyperlipidemia
    Gillian M. Keating
    American Journal of Cardiovascular Drugs, 2016, 16 : 67 - 78
  • [9] Evolocumab in Hyperlipidemia REPLY
    Blom, Dirk J.
    Wasserman, Scum M.
    Stein, Evan A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (09): : 877 - 878
  • [10] Evolocumab: Considerations for the Management of Hyperlipidemia
    Barbara S. Wiggins
    Jeffrey Senfield
    Helina Kassahun
    Armando Lira
    Ransi Somaratne
    Current Atherosclerosis Reports, 2018, 20
12345